These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26925649)

  • 21. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.
    Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC
    Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
    Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y
    Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.
    Jia J; Zheng X; Chen Y; Wang L; Lin L; Ye X; Chen Y; Chen D; Dettke M
    Tumour Biol; 2015 Dec; 36(12):9319-25. PubMed ID: 26104767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
    Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
    Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
    Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.
    Kishiki T; Masaki T; Matsuoka H; Kobayashi T; Suzuki Y; Abe N; Mori T; Sugiyama M
    Am J Surg; 2013 Aug; 206(2):234-40. PubMed ID: 23827511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
    Shin JS; Suh KW; Oh SY
    J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
    Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
    Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
    Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
    World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
    Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
    World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.